Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome

NCT00006185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

HIV Infections
Lipodystrophy
Insulin Resistance

Interventions

DRUG: Avandia administration for 6-12 weeks

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)